Seeking Alpha
 

Beckman Coulter, Inc. (BEC)

- NYSE
BEC is defunct.
  • Feb. 7, 2011, 9:00 AM
    Premarket gainers: PDE +17%. BEC +10%. PGNX +9%. INO +5%. GLUU +5%. OREX +5%. DHR +5%. EMKR +4%. MGIC +4%. CHK +4%. AIB +4%.
    Losers: YONG -10%. WY -5%. SYY -4%.
    | Comment!
  • Feb. 7, 2011, 7:19 AM
    Danaher (DHR) will pay $6.8B, or $83.50/share, for Beckman Coulter (BEC). It's a 45% premium to Beckman's close on Dec. 9, 2010, before acquisitions rumors started to fly. (PR) (previously)
    | Comment!
  • Feb. 4, 2011, 8:11 AM
    Beckman Coulter (BEC) has received second-round takeover offers, including one from an alliance of Blackstone (BX) and TPG Capital and another consisting of Apollo Global Management and Carlyle Group. The medical diagnostics firm has a market valuation of at least $5B, which would make it one of the largest leveraged buyouts since the credit crisis.
    | Comment!
  • Jan. 28, 2011, 1:56 PM
    KKR drops out of a bidding group for Beckman Coulter (BEC -1%), leaving TPG Capital and Blackstone Group (BX) to come up with extra funding or find another investor, Bloomberg reports. KKR was said to be concerned that the price for Beckman might get too high amid interest by strategic bidders such as Danaher (DHR).
    | Comment!
  • Jan. 8, 2011, 2:23 PM
    Strategic buyers are losing interest in Beckman Coulter (BEC), sources say, as the medical testing company's stock has risen substantially since possible sale rumors began to circulate last month. If a deal materializes, it could be from P-E firms that team up for the bid.
    | Comment!
  • Dec. 10, 2010, 9:00 AM
    Premarket gainers: THC +52%. BEC +26%. MGH +12%. DRYS +5%. CVC +5%. IBN +5%. NFLX +4%. FFIV +4%.
    Losers: GMCR -14%. FSYS -6%. NSM -5%. CYH -4%. CYS -4%.
    | Comment!
  • Dec. 10, 2010, 7:21 AM
    Beckman Coulter (BEC) is looking to sell itself, sources say, and has hired Goldman (GS) to help it navigate a deal that could bring in more than $5B. A sale is at least several weeks away and may not happen at all, but speculation is boosting the stock; shares climbed 18% in AH trading yesterday.
    | Comment!
  • Oct. 27, 2010, 4:43 PM
    Beckman Coulter (BEC): Q3 EPS of $1.00 beats by $0.12. Revenue of $894M (+8.6%) vs. $885M. Shares +3.5% AH. (PR)
    | Comment!
  • Oct. 27, 2010, 12:10 AM
    Notable earnings after Wednesday's close: AB, ACE, AEM, AHL, AIZ, ALL, AMP, ARRS, AVB, BDN, BEC, BEZ, BYI, CACI, CAVM, CCI, CDNS, CHH, CINF, CYH, DRE, DRYS, EEP, EFX, EQR, ESRX, FLEX, FLS, FMC, FTI, GG, GSIC, HBI, HLX, HMA, HRC, ICO, IDCC, ITRI, KEG, KEX, LOGI, LSI, MANT, MDAS, MORN, NSC, O, OI, ORLY, OTEX, PLXS, PRAA, RNR, RRC, SCI, SKX, SPN, SRCL, SXL, SYMC, TER, TMK, TQNT, TRN, UHS, V, WLL, WRE, WSH
    | Comment!
  • Jul. 23, 2010, 9:00 AM
    Premarket gainers: KWK +17%. ARMH +12%. CRBC +11%. RAS +10%. ETFC +9%. F +5%. SCCO +5%. VZ +4%.
    Losers: BEC -17%. AMZN -11%. SNV -7%. ERIC -6%. SNDK -5%.
    | Comment!
  • Feb. 9, 2009, 4:16 PM
    Beckman Coulter (BEC): Q4 EPS of $1.21 misses by $0.01. Revenue of $811M (+2.8%) in-line. (PR)
    | Comment!
  • Dec. 16, 2008, 9:40 AM
    Beckman Coulter (BEC): Sees 2008 EPS $3.55-$3.65 vs. consensus of $3.59, and revenue up ~12%. Operating margin on par with 2007 at 11.5-12%. In this environment, that's good news. Shares +11%. (PR)
    | Comment!
  • Jul. 25, 2008, 12:03 AM
    Notable earnings before Friday's open: ACI, AXL, B, BDK, BEC, CVH, FO, IFX, ITT, LM, NFLX, SRP, TROW
    | Comment!
Visit Seeking Alpha's
Company Description
From complex DNA sequencing in pioneering research laboratories and high-volume laboratory testing in hospitals to simple single-use diagnostic screening kits used in physicians’ offices, Beckman Coulter is the world’s largest company devoted solely to biomedical testing. We estimate this market... More